The protein Argonaute 2 was found to be critical to the progression from benign lesions into pancreatic cancer, suggesting a therapeutic opportunity.

University of Michigan research shows the direct correlation between systemic racism and racial health disparities in the United States.

A new precision medicine analytics tool called TransPRECISE developed to help oncologists with cancer treatment and research.

In mouse models with a deadly form of pediatric brain cancer, an immune stimulatory gene therapy increased median survival.

Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment.

Beating cancer and recovering from a leg amputation imposed its own form of isolation on Kara Wolter, but now, ready to get back to her lifelong love of swimming, the COVID-19 pandemic has imposed new restrictions.

Using next-generation RNA sequencing combined with data from local sources and The Cancer Genome Atlas, U-M researchers have uncovered the gene signature for chromophobe renal cell carcinoma (ChRCC).

A new study examines why different types of gut bacteria impact the development or suppression of colorectal cancer in mice.

Antiandrogen treatment is associated with heart and neurological problems and didn’t increase survival for this group of men, a U-M analysis finds.

An international team of radiation oncologists are helping to protect patients and providers and conserve protective equipment for frontline health care workers during the COVID-19 pandemic.

After receiving a rare cancer diagnosis, one local pastor says she has learned more about what unconditional love means.

Brain cancer researchers discover an intracellular signaling pathway active in glioma cells that regulates the tumor microenvironment.

Improving outcomes for pancreatic cancer patients has been a long, slow road, but Michigan Medicine doctors are staying the course and are developing new methods of treatment for the disease.

Cervical cancer is considered preventable in its early stages, but without breaking down barriers to prevention, women in certain countries remain at high risk.

For children diagnosed with high risk brain tumors, an exclusive global network helps promising clinical trials underway.